Skip to content
10-Q

Quarterly Report

ASSEMBLY BIOSCIENCES, INC. ASMB

0000950170-25-066991

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 7.64M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $23.41M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $38.34M
Current Liabilities Q1 2025 · Mar 31, 2025 $46.63M
Current Liabilities Q1 2025 · Dec 31, 2024 $47.8M
Total Liabilities Q1 2025 · Mar 31, 2025 $71.88M
Total Liabilities Q1 2025 · Dec 31, 2024 $85.81M
Current Assets Q1 2025 · Mar 31, 2025 $95.53M
Current Assets Q1 2025 · Dec 31, 2024 $115.5M
Total Assets Q1 2025 · Mar 31, 2025 $99.02M
Total Assets Q1 2025 · Dec 31, 2024 $119.17M
Shares Diluted Q1 2025 · Mar 31, 2024 5.48M sh
Capex Q1 2025 · Mar 31, 2024 $14K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$18.36M
Stockholders Equity Q1 2025 · Mar 31, 2024 $32.6M
Stockholders Equity Q1 2025 · Dec 31, 2023 $41.1M
Eps Diluted Q1 2025 · Mar 31, 2024 −$1.66
Eps Basic Q1 2025 · Mar 31, 2024 −$1.66
Sga Expense Q1 2025 · Mar 31, 2024 $4.64M
Rd Expense Q1 2025 · Mar 31, 2024 $11.88M
Net Income Q1 2025 · Mar 31, 2024 −$9.08M
Operating Income Q1 2025 · Mar 31, 2024 −$10.73M